Le Lézard
Classified in: Science and technology, Business
Subjects: TDS, OTC

Appiphany Technologies Announces Attendance and Both IACC and INTA Conferences in Barcelona, Spain


SALT LAKE CITY, May 16, 2017 /PRNewswire/ --

Appiphany Technologies (OTC: APHD), which provides private enterprise with total, integrated brand protection solutions to prevent revenue loss from counterfeiting, product diversion and gray market activities, is pleased to announce their attendance at both the International Anti-Counterfeiting Coalition (IACC) and the International Trademark Association (INTA) conferences being held this week in Barcelona, Spain. The two events run from May 17th to May 24th, 2017. Appiphany's Advisory Board Member Deborah Greaves will be there as well as referral partners from Canada the U.S.

The INTA annual meeting continues to grow with over 9,500 attendees from more than 140 countries, and is an essential tool for the best practices for global trademark practitioners, especially for issues of legal education and networking among the world's finest lawyers. The IACC conference gathers the world's top brands, enforcement officials and service firms globally.

Appiphany CEO, Rob Sargent, stated, "For over a decade we have had representation at these two key industry events. Intellectual property counsel and security enforcement firms are the lifeblood of our business and we are pleased to be represented once again."

Advisory Board member, Deborah Greaves is an Intellectual Property attorney specializing in the representation of fashion and consumer brands at Ezra Britzkas Gunner LLP, Los Angeles. Deborah was a former Secretary and General Counsel of True Religion Brand Jeans, a publicly-traded premium apparel company. She has been a legal practitioner in the fashion and consumer products industry for more than 16 years.

Follow news directly at:

http://ipriskcontrol.com/blog/

https://twitter.com/IPRiskControl

About Appiphany Technology Holdings Corp. 

Appiphany Technology (OTCPK: APHD) (IP Risk Control) (http://www.ipriskcontrol.com) has diversified offerings to deliver global 'best-of-breed' products and technologies that combat counterfeit and theft of global goods, data and cyber security protection. The Company continues to develop its own technologies and has an active acquisitions program in place.

Forward-Looking Statements 

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Appiphany's filings with the SEC, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Contact Info:
Media Relations
[email protected]
+1-385-212-3295

http://www.ipriskcontrol.com



SOURCE Appiphany Technology Holdings Corp.


These press releases may also interest you

at 06:23
IDTechEx, a trusted provider of independent market intelligence, have released a new market report, "Thermal Interface Materials 2024-2034: Technologies, Markets, and Forecasts". The report forecasts the global TIM market size will reach around...

at 06:16
Aramco, one of the world's leading integrated energy and chemicals companies, has signed an agreement with Pasqal, a global leader in neutral atom quantum computing, to install the first quantum computer in the Kingdom of Saudi Arabia. The agreement...

at 06:09
Béné Tipping, the premier digital tipping platform for hospitality service providers, announced the launch of a first-of-its-kind cashless tipping platform that allows employers and customers to team up on tipping. This unique feature fixes the...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:01
ADAMA Ltd. (SZSE 000553), a leading global crop protection company, today published its 2023 Environmental, Social and Governance (ESG) Report. The report details the company's commitment to transparency and incorporating several key standards from...



News published on and distributed by: